Previous post Next post

Swiss drugmaker Sandoz settles US anti-trust charges

Swiss drugmaker Sandoz settles US anti-trust charges
Sandoz reaches further settlement in the USA Keystone-SDA

The Swiss generic drugs manufacturer Sandoz has agreed to pay more than $500 million to settle legacy United States anti-trust legal issues.

+Get the most important news from Switzerland in your inbox

Sandoz has reached a settlement agreement with the class of final claimants for $275 million, according to a statement on Tuesday. In addition, provisions of $265 million have been set aside to cover potential further settlement costs for antitrust proceedings in the US generics industry.

These measures have no impact on the current annual forecast or the medium-term targets, it added. In recent years, Sandoz has gradually cleared up its legal legacy. The Group had already reached settlements with the US Department of Justice in 2020 and 2021. Then, in February of this year, with the plaintiff group of direct purchasers.

The settlement now announced with the class of ultimate purchasers, which includes consumers, insurers and social insurance companies, is expected to be paid before December 31, 2024. According to the information provided, the settlement still has to be approved by the court.

Translated from German by DeepL/mga

This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles.

If you want to know more about how we work, have a look here, if you want to learn more about how we use technology, click here, and if you have feedback on this news story please write to [email protected].

Full story here Are you the author?
About Swissinfo
Swissinfo
SWI swissinfo.ch – the international service of the Swiss Broadcasting Corporation (SBC). Since 1999, swissinfo.ch has fulfilled the federal government’s mandate to distribute information about Switzerland internationally, supplementing the online offerings of the radio and television stations of the SBC. Today, the international service is directed above all at an international audience interested in Switzerland, as well as at Swiss citizens living abroad.
Previous post See more for 3.) Swissinfo Business and Economy Next post
Tags: ,

Permanent link to this article: https://snbchf.com/2024/12/swiss-drugmaker-sandoz-settles-trust-charges/

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

This site uses Akismet to reduce spam. Learn how your comment data is processed.